Pluri Inc./$PLUR

13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX

About Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Ticker

$PLUR
Sector
Primary listing

Employees

135

Headquarters

Haifa, Israel

Pluri Inc. Metrics

BasicAdvanced
$36M
-
-$3.56
0.69
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PLUR

Sign up or log in to buy
Capital at risk
Market closedLow-cap

Upcoming events

No upcoming events
FAQs
Buy Pluri Inc. stock | $PLUR Share Price | Lightyear